Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.

Secretory phospholipase A2 (sPLA2) type IIA and X was analyzed in tumors from 22 patients with colon adenocarcinomas in order to determine the involvement and activity of sPLA2 in colon cancer. Evaluation of immunoreactive sPLA2 IIA by Western blotting showed a significantly higher level in the periphery of the tumors, compared to central tumor regions. Increased levels of sPLA2 IIA protein correlated with a two-fold increase in sPLA2 enzymatic activity in the peripheral regions compared to central regions. Nineteen out of 22 tumors showed high levels of sPLA2 IIA, whereas 7 out of the 22 tumors showed sPLA2 type X. These data demonstrate that both sPLA2 type IIA and X are present in human colon cancer and suggest a role for sPLA2 in colon cancer tumor immunology and tumorigenesis.

[1]  Liang Cheng,et al.  Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. , 2002, The American journal of pathology.

[2]  H. Kamohara,et al.  Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer , 1997, International journal of cancer.

[3]  H. Tojo,et al.  Enhanced expression of group II phospholipase A2 in human hepatocellular carcinoma. , 1994, Biochimica et biophysica acta.

[4]  T. Callisen,et al.  Increase in phospholipase A2 activity towards lipopolymer-containing liposomes. , 1998, Biochimica et biophysica acta.

[5]  O. G. Mouritsen,et al.  Biophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery , 2002, FEBS letters.

[6]  R. Golouh,et al.  Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Friess,et al.  Group II and IV phospholipase A2 are produced in human pancreatic cancer cells and influence prognosis , 1999, Gut.

[9]  G. Graham,et al.  Secreted phospholipase A2 enzymes as therapeutic targets , 2003, Expert opinion on therapeutic targets.

[10]  H. Arita,et al.  Potential role of group X secretory phospholipase A2 in cyclooxygenase‐2‐dependent PGE2 formation during colon tumorigenesis , 2000, FEBS letters.

[11]  K. Kawamoto,et al.  Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells* , 1999, The Journal of Biological Chemistry.

[12]  M. Gelb,et al.  Bactericidal Properties of Human and Murine Groups I, II, V, X, and XII Secreted Phospholipases A2 * , 2002, The Journal of Biological Chemistry.

[13]  James G. Bollinger,et al.  On the Binding Preference of Human Groups IIA and X Phospholipases A2 for Membranes with Anionic Phospholipids* , 2002, The Journal of Biological Chemistry.

[14]  M. Ogawa.  Group II Phospholipase A2 in Neoplastic Diseases , 1997 .

[15]  M. Schwab,et al.  Secretory Type II Phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa , 1998, Oncogene.

[16]  B. Linebaugh,et al.  Phospholipase A2 activity in 9,10-dimethyl-1,2-benzanthracene-induced mammary tumors of rats. , 1980, Biochimica et biophysica acta.

[17]  G. Lambeau,et al.  Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. , 2000, Biochimica et biophysica acta.

[18]  B. Johansen,et al.  Phospholipase A2 in Psoriasis , 1997 .

[19]  K. Fransén,et al.  Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas. , 2002, Cancer letters.

[20]  S. Prescott,et al.  Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer , 2002, Journal of cellular physiology.

[21]  Eric S. Lander,et al.  Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis , 1997, Nature Genetics.

[22]  E. Dennis,et al.  Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. , 1999, Analytical biochemistry.

[23]  P. Söderkvist,et al.  Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. , 1998, Anticancer research.

[24]  L. Guglielmi,et al.  Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients , 2003, Oncogene.

[25]  J. Neoptolemos,et al.  Activities of phospholipase A2 and diacylglycerol lipase are increased in human colorectal cancer , 1995, The British journal of surgery.

[26]  M. Urowitz,et al.  Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. , 1985, The Journal of rheumatology.

[27]  H. Tojo,et al.  A phospholipase A2 in the supernatant fraction of rat spleen. Its similarity to rat pancreatic phospholipase A2. , 1988, The Journal of biological chemistry.

[28]  L. Touqui,et al.  A role for phospholipase A2 in ARDS pathogenesis. , 1999, Molecular medicine today.

[29]  H. Arita,et al.  Group X secretory phospholipase A(2) induces potent productions of various lipid mediators in mouse peritoneal macrophages. , 2001, Biochimica et biophysica acta.

[30]  E. Dennis,et al.  The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. , 2000, Biochimica et biophysica acta.

[31]  R. A. Blackwood,et al.  PLA2 promotes fusion between PMN‐specific granules and complex liposomes , 1996, Journal of leukocyte biology.

[32]  M. Ogawa,et al.  Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. , 1993, British Journal of Cancer.

[33]  J. Yamashita,et al.  Increased expression of membrane‐associated phospholipase A2 shows malignant potential of human breast cancer cells , 1993, Cancer.

[34]  J. Deddens,et al.  Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  W. B. Church,et al.  A Novel Approach to the Design of Inhibitors of Human Secreted Phospholipase A2 Based on Native Peptide Inhibition* 210 , 2001, The Journal of Biological Chemistry.

[36]  L. Jenski,et al.  Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation , 2002, Anti-cancer drugs.

[37]  Jon Laye,et al.  Phospholipase A2 expression in tumours: a target for therapeutic intervention? , 2003, Drug discovery today.

[38]  M. Gelb,et al.  Interfacial Kinetic and Binding Properties of the Complete Set of Human and Mouse Groups I, II, V, X, and XII Secreted Phospholipases A2 * , 2002, The Journal of Biological Chemistry.

[39]  P. Weech,et al.  High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue. , 1996, European journal of cancer.

[40]  G. Rice,et al.  Contribution of type II phospholipase A2 to in vitro phospholipase A2 enzymatic activity in human term placenta. , 1998, The Journal of endocrinology.

[41]  O. G. Mouritsen,et al.  Secreted phospholipase A(2) as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue. , 2003, Biochimica et biophysica acta.

[42]  B. Kennedy,et al.  Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. , 1998, Cancer research.

[43]  A. Mukherjee,et al.  The localization of phospholipase A2 in the secretory granule. , 1994, The Biochemical journal.

[44]  T. Nevalainen,et al.  Group II PLA(2) content of tears in normal subjects. , 2001, Investigative ophthalmology & visual science.